Malignant Pleural Mesothelioma: Pleural Decortication and Multimodal Therapy
Malignant pleural mesothelioma is a severe cancer caused by asbestos exposure. It impacts the lungs’ lining. Treating it is tough,…
Mesothelioma Treatment: Understanding Cytoreductive Surgery and HIPEC
Peritoneal mesothelioma is a rare cancer linked to asbestos exposure. It’s aggressive. However, a promising option combines cytoreductive surgery (CRS)…
Challenges of Diagnosing Mesothelioma: Importance of Early Detection and Insights from a Cancer Registry
Malignant mesothelioma, an aggressive cancer from asbestos, mainly affects the pleura. However, it also harms other tissues like the peritoneum.…
Mesothelioma Clinical Trials: Insights from the MARS 2 Study
Malignant pleural mesothelioma is a rare, aggressive cancer. It affects the chest wall’s lining, linked to asbestos exposure. Each year,…
Mesothelioma Carcinogenesis: Insights from Animal Studies on Chrysotile and Forsterite
Mesothelioma, a severe cancer caused by asbestos, remains a global health issue. Specifically, chrysotile asbestos is common and very harmful.…
Comprehensive Genomic Profiling in Pediatric Peritoneal Mesothelioma
Mesothelioma is a serious cancer in the lining of body cavities. It affects people of all ages. Although rare in…
Breaking Through the Treatment Desert of CAR-T Cell Therapy for Malignant Mesothelioma
Malignant mesothelioma is a rare and aggressive cancer caused by asbestos exposure. Treatment options are limited. This is especially true…
Mesothelioma in Elderly Patients: An Uncommon Case of Benign Multicystic Peritoneal Mesothelioma
Mesothelioma is a type of cancer caused by asbestos exposure. It often evokes thoughts of aggressive malignancies. But, there are…
Navigating Ipilimumab and Nivolumab Treatment for Mesothelioma: Insights from the United Kingdom
Being diagnosed with mesothelioma is tough. However, it’s vital to know about new treatments and their effects. In the United…
Navigating the Complexities of Immunotherapy for Mesothelioma: Insights for Patients and Caregivers
Mesothelioma is a rare, aggressive cancer that poses challenges for patients and caregivers. Recently, immune checkpoint inhibitors have brought hope…